Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ADVR - Bulls no Bears -- Ignore unavailable to you. Want to Upgrade?

To: OLD JAKE JUSTUS who wrote (911)	2/25/1998 10:49:00 PM
From: Dman	Read Replies (1) \| Respond to of 913

I recently called ADVR and was told that they had just hired 4 more scientists. This sounds very positive. What is strange is that this drug, Reticulose, was approved for use back in the 40's, 50's and 60's. During the 60's there was some scare about new drugs and it got pulled from the FDA approval list along with hundreds of other drugs. During WWII it was used to help GI's fight infections in Europe and Asia. What I don't get is why hasn't this drug been reapproved. I know the FDA is political but, Hey if this was owned by Merck, it would have been put through already. Any thoughts on this?